Dave Fornell, DAIC Editor

Dave Fornell, editor of DAIC Magazine

Blog | Dave Fornell, DAIC Editor | Business| August 18, 2017

CMS Will Likely Cancel Mandatory Cardiac Bundled Payments

The Centers for Medicare and Medicaid Services (CMS) in August announced a proposed rule to cancel the Episode Payment Models (EPMs) for cardiac bundled payments for patients with acute chest pain. The proposed rule also may eliminate the cardiac rehabilitation (CR) incentive payment model. Acute cardiac care bundled payments for patients with myocardial infarction who undergo percutaneous coronary intervention (PCI) with or without stenting, or coronary bypass graft surgery (CABG), was supposed to go into effect July 1, 2017. CMS pushed this back to Jan. 1, 2018, but is now considering making these payment models voluntary. 

CMS said eliminating these models would give the agency greater flexibility to design and test innovations that will improve quality and care coordination across the in-patient and post-acute care spectrum. Moving forward, CMS expects to increase opportunities for providers to participate in voluntary initiatives rather than large mandatory episode payment model efforts. The changes in the proposed rule would allow the agency to engage providers in future voluntary efforts, including additional voluntary episode-based payment models. 

Of course there is also a political component. CMS has delayed these bundled payment initiatives twice since President Trump appointed Health and Human Services (HHS) Secretary Tom Price, M.D., and CMS Administrator Seema Verma, MPH. Both have been critics of mandatory bundled payments. 

The original intent of the bundled payments was to move away from traditional fee-for-service reimbursement to a fee-for-value model. The idea was to force hospitals to become more efficient in order to reduce their healthcare costs. However, while the concept may sound good on paper, there have been many complaints from clinical advocacy groups that say there are numerous areas of the bundled payment plan that could negatively impact patient care as hospitals look to do the bare minimum to treat a Medicare patient so they do not spend more than CMS would pay them. 

The Society for Cardiovascular Angiography and Interventions (SCAI) has been closely watching developments regarding a proposed HHS/CMS rule. In April, SCAI expressed concerns in a letter to Secretary Price and recommended revisions to the bundled payment program. The society applauded the delay of implementing these payment models until 2018 and has advocated for a purely voluntary program. SCAI said this is because many hospitals are not yet prepared to meet the rigors of the program. The society also detailed specific concerns:
• CMS should recognize the ACC/NCDR as a voluntary option so a hospital can make risk-adjustments for the acute myocardial infarction (AMI) bundled payment program.
• Add the AMI CPT Code 92941 to the inpatient-only list so patients are not relegated to outpatient/observation status. SCAI also asked CMS to exclude any non-STEMI PCI cases reported using code 9294 from the bundled payment program.
• Exclude cardiogenic shock and out-of-hospital cardiac arrest patients from the program.
• Exempt patients from the program that have myocardial infarction (MI) as a secondary diagnosis.
• Narrow the 90-day bundled payment period down to 30 days.
• Remove multi-vessel disease patients from bundled payments because they may not receive optimal care with additional stents because of fears of additional cost.
• CMS should consider and track the use of bare metal vs. drug-eluting stents in the program, as hospitals may opt for the less expensive bare metal stents and patients might end up with poor long-term outcomes.

Read the full article “CMS to Cancel Mandatory Cardiac Bundled Payments and Cardiac Rehabilitation Payment Model.”

Watch the VIDEO "MACRA's Impact on Cardiology," an interview with Kim Williams, M.D.

Read the article "Preparing for Cardiology Bundled Payments."

Related Content

Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology| September 26, 2017
Treatment of heart attack patients depends on their history of cancer, according to research published recently in...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Overlay Init